Stocks and securities in focus
Security | Change (%) | 1w ▲ | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cardiff Oncology Inc. | -5.890% | -22.289% | -40.388% | 91.055% | 145.061% | -57.000% | -7.857% |
ImmunityBio Inc. | 6.240% | -13.467% | 37.638% | 44.960% | 53.559% | -45.356% | - |
Illumina Inc. | -5.050% | -5.004% | -6.293% | -39.015% | -14.023% | -64.635% | -61.903% |
Intra-Cellular Therapies Inc. | -3.030% | -2.222% | 3.937% | 17.438% | 1.227% | 147.934% | 424.642% |
BioMarin Pharmaceutical Inc. | 0.420% | -0.470% | -4.842% | -13.044% | -13.124% | 17.071% | 2.061% |
Biogen Inc. | -1.170% | 2.238% | 9.275% | -28.809% | -12.807% | -8.805% | -2.536% |
Viking Therapeutics Inc | 2.180% | 3.240% | 3.065% | 250.241% | 315.442% | 1419.983% | - |
X4 Pharmaceuticals, Inc. | -12.970% | 4.074% | -15.512% | -30.325% | 37.564% | - | - |
Cytomx Therapeutics Inc | -5.700% | 168.602% | 113.641% | 164.416% | 191.691% | -39.852% | - |